The independent, third-party certification confirms that the company's facility and EU GMP CBD products have attained NSF Certified for Sport certificationVANCOUVER, British Columbia, Nov. 22, 2022 (GLOBE
/PRNewswire/ - Brains Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in pharmaceutical EU-GMP grade Cannabidiol (CBD) Active Pharmaceutical.
The approved investigational new drug study is for a PK study to use as a precursor in an Opiate addiction study VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ - Brains Bioceutical Corp , a global.